Your browser doesn't support javascript.
loading
Long-term follow-up from a phase 1/2 study of single-agent bortezomib in relapsed systemic AL amyloidosis.
Reece, Donna E; Hegenbart, Ute; Sanchorawala, Vaishali; Merlini, Giampaolo; Palladini, Giovanni; Bladé, Joan; Fermand, Jean-Paul; Hassoun, Hani; Heffner, Leonard; Kukreti, Vishal; Vescio, Robert A; Pei, Lixia; Enny, Christopher; Esseltine, Dixie-Lee; van de Velde, Helgi; Cakana, Andrew; Comenzo, Raymond L.
Affiliation
  • Reece DE; Princess Margaret Cancer Center, Toronto, ON, Canada;
  • Hegenbart U; Amyloidosis Center, University of Heidelberg, Heidelberg, Germany;
  • Sanchorawala V; Boston University Medical Center, Boston, MA;
  • Merlini G; Amyloidosis Research and Treatment Center, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Policlinico San Matteo, Department of Molecular Medicine, University of Pavia, Pavia, Italy;
  • Palladini G; Amyloidosis Research and Treatment Center, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Policlinico San Matteo, Department of Molecular Medicine, University of Pavia, Pavia, Italy;
  • Bladé J; Hematology Department, Institute of Hematology and Oncology, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clínic, University of Barcelona, Barcelona, Spain;
  • Fermand JP; Hôpital Saint Louis, Paris, France;
  • Hassoun H; Memorial Sloan-Kettering Cancer Center, New York, NY;
  • Heffner L; Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA;
  • Kukreti V; Princess Margaret Cancer Center, Toronto, ON, Canada;
  • Vescio RA; Cedars-Sinai Medical Center, Los Angeles, CA;
  • Pei L; Janssen Research and Development, LLC, Raritan, NJ;
  • Enny C; Janssen Research and Development, LLC, Raritan, NJ;
  • Esseltine DL; Takeda Pharmaceuticals International Co., Cambridge, MA;
  • van de Velde H; Janssen Research and Development, Division of Janssen Pharmaceutica NV, Beerse, Belgium;
  • Cakana A; Janssen Research and Development, High Wycombe, United Kingdom; and.
  • Comenzo RL; Tufts Medical Center, Boston, MA.
Blood ; 124(16): 2498-506, 2014 Oct 16.
Article in En | MEDLINE | ID: mdl-25202139
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazines / Boronic Acids / Amyloidosis / Antineoplastic Agents Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Blood Year: 2014 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazines / Boronic Acids / Amyloidosis / Antineoplastic Agents Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Blood Year: 2014 Type: Article